These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20697987)

  • 1. Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression.
    Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
    Tumour Biol; 2011 Feb; 32(1):23-32. PubMed ID: 20697987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
    Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
    Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and regulation of tumor suppressor gene maspin in breast cancer.
    Maass N; Nagasaki K; Ziebart M; Mundhenke C; Jonat W
    Clin Breast Cancer; 2002 Oct; 3(4):281-7. PubMed ID: 12425757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant methylation of the maspin promoter is an early event in human breast cancer.
    Futscher BW; O'Meara MM; Kim CJ; Rennels MA; Lu D; Gruman LM; Seftor RE; Hendrix MJ; Domann FE
    Neoplasia; 2004; 6(4):380-9. PubMed ID: 15256060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
    Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
    Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
    Ramezani F; Salami S; Omrani MD; Maleki D
    Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maspin expression and subcellular localization in invasive ductal carcinoma of the breast: Prognostic significance and relation to microvessel density.
    Helal DS; El-Guindy DM
    J Egypt Natl Canc Inst; 2017 Dec; 29(4):177-183. PubMed ID: 29126758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
    Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
    Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Protein Expression and Methylation of DAPK1 with Clinicopathological Features in Invasive Ductal Carcinoma Patients from Kashmir.
    Asiaf A; Ahmad ST; Malik AA; Aziz SA; Zargar MA
    Asian Pac J Cancer Prev; 2019 Mar; 20(3):839-848. PubMed ID: 30912402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression analysis of maspin in invasive ductal carcinoma of breast and modulation of its expression by curcumin in breast cancer cell lines.
    Prasad CP; Rath G; Mathur S; Bhatnagar D; Ralhan R
    Chem Biol Interact; 2010 Feb; 183(3):455-61. PubMed ID: 19944674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological significance of maspin expression in breast cancer.
    Lee MJ; Suh CH; Li ZH
    J Korean Med Sci; 2006 Apr; 21(2):309-14. PubMed ID: 16614520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Slit2 promoter hypermethylation in tissue and serum samples from breast cancer patients.
    Kim GE; Lee KH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
    Virchows Arch; 2011 Oct; 459(4):383-90. PubMed ID: 21894562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.
    Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C
    Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of promoter hypermethylation of ERβ and RARβ2 in tumor and serum DNA in Indian breast cancer patients.
    Mirza S; Sharma G; Parshad R; Srivastava A; Gupta SD; Ralhan R
    Ann Surg Oncol; 2012 Sep; 19(9):3107-15. PubMed ID: 22451234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
    Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
    Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of cyclin D1, β-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast.
    Cheng CW; Liu YF; Yu JC; Wang HW; Ding SL; Hsiung CN; Hsu HM; Shieh JC; Wu PE; Shen CY
    Ann Surg Oncol; 2012 Dec; 19(13):4129-39. PubMed ID: 22864797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation of ARID1A gene is responsible for its low mRNA expression in many invasive breast cancers.
    Zhang X; Sun Q; Shan M; Niu M; Liu T; Xia B; Liang X; Wei W; Sun S; Zhang Y; Liu XS; Song Q; Yang Y; Ma Y; Liu Y; Yang L; Ren Y; Zhang G; Pang D
    PLoS One; 2013; 8(1):e53931. PubMed ID: 23349767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between VEGF and MTA1 signaling pathways contribute to aggressiveness of breast carcinoma.
    Nagaraj SR; Shilpa P; Rachaiah K; Salimath BP
    Mol Carcinog; 2015 May; 54(5):333-50. PubMed ID: 24265228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maspin and c-erbB-2 expression in correlation with microvessel density in invasive ductal breast cancer.
    Sopel M; Kasprzyk I; Berdowska I
    Folia Histochem Cytobiol; 2005; 43(2):109-16. PubMed ID: 16044948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear location of tumor suppressor protein maspin inhibits proliferation of breast cancer cells without affecting proliferation of normal epithelial cells.
    Machowska M; Wachowicz K; Sopel M; Rzepecki R
    BMC Cancer; 2014 Feb; 14():142. PubMed ID: 24581141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.